SCHEMBL6175280

SCHEMBL6175280

CC(C=C(OC(=O)OC(=CC(C)[Si](C)(C)C)c1ccccc1)c1ccccc1)[Si](C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
HTR2A P28223 1/20 0.36
HRH1 P35367 1/20 0.36
KCNH2 Q12809 1/20 0.36
TSHR P16473 1/20 0.35
ATM Q13315 2/20 0.35
LMNA P02545 2/20 0.35
MAPT P10636 1/20 0.35
XBP1 P17861 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ELANE P08246 1/20 0.34
HCAR2 Q8TDS4 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
GABRA5 P31644 1/20 0.34
MTNR1A P48039 3/20 0.33
MTNR1B P49286 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6175285 0.90 PGR (0.36) PGRADRA2AADRA2BHTR2AHRH1
SCHEMBL7132464 0.75 TSHR (0.45) TSHRLMNAMAPTMEN1KMT2A
SCHEMBL6175771 0.72 MTNR1A (0.39) TSHRLMNAMAPTSMN1; SMN2ELANE
SCHEMBL7128884 0.69 CES1 (0.46) TSHRATMLMNAMAPTSMN1; SMN2
SCHEMBL6175281 0.69 TSHR (0.41) TSHRMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL27335278 0.69 TSHR (0.41) TSHRMAPTSMN1; SMN2MEN1KMT2A
SCHEMBL703633 0.68 AKR1C1 (0.52) TSHRLMNAMAPTMEN1KMT2A
SCHEMBL29006131 0.62 TSHR (0.54) TSHRLMNAMAPTSMN1; SMN2KMT2A
SCHEMBL29180078 0.62 ELANE (0.46) TSHRLMNAMAPTELANEMEN1
SCHEMBL9848566 0.62 ELANE (0.46) TSHRLMNAMAPTELANEMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1203770-B1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases UPJOHN CO (US) 2005-03-09 EP disclosed
EP-0668860-B1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES UPJOHN CO (US) 2002-09-11 EP disclosed
EP-1203770-A1 Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hyperplasia and other diseases PHARMACIA & UPJOHN COMPANY (US) 2002-05-08 EP disclosed
WO-1994011361-A1 PYRAN-2-ONES AND 5,6-DIHYDROPYRAN-2-ONES USEFUL FOR TREATING HIV AND OTHER RETROVIRUSES THE UPJOHN COMPANY (US) 1994-05-26 WO disclosed